Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy

Radiotherapy represents a highly targeted and efficient treatment choice in many cancer types, both with curative and palliative intents. Nevertheless, radioresistance, consisting in the adaptive response of the tumor to radiation-induced damage, represents a major clinical problem. A growing body o...

Full description

Bibliographic Details
Main Authors: Mattia Zaffaroni, Maria Giulia Vincini, Giulia Corrao, Giulia Marvaso, Matteo Pepa, Giuseppe Viglietto, Nicola Amodio, Barbara Alicja Jereczek-Fossa
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/19/11343
_version_ 1797479100543139840
author Mattia Zaffaroni
Maria Giulia Vincini
Giulia Corrao
Giulia Marvaso
Matteo Pepa
Giuseppe Viglietto
Nicola Amodio
Barbara Alicja Jereczek-Fossa
author_facet Mattia Zaffaroni
Maria Giulia Vincini
Giulia Corrao
Giulia Marvaso
Matteo Pepa
Giuseppe Viglietto
Nicola Amodio
Barbara Alicja Jereczek-Fossa
author_sort Mattia Zaffaroni
collection DOAJ
description Radiotherapy represents a highly targeted and efficient treatment choice in many cancer types, both with curative and palliative intents. Nevertheless, radioresistance, consisting in the adaptive response of the tumor to radiation-induced damage, represents a major clinical problem. A growing body of the literature suggests that mechanisms related to mitochondrial changes and metabolic remodeling might play a major role in radioresistance development. In this work, the main contributors to the acquired cellular radioresistance and their relation with mitochondrial changes in terms of reactive oxygen species, hypoxia, and epigenetic alterations have been discussed. We focused on recent findings pointing to a major role of mitochondria in response to radiotherapy, along with their implication in the mechanisms underlying radioresistance and radiosensitivity, and briefly summarized some of the recently proposed mitochondria-targeting strategies to overcome the radioresistant phenotype in cancer.
first_indexed 2024-03-09T21:40:54Z
format Article
id doaj.art-32b8c40b6e144c90be5664a97a5355e7
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T21:40:54Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-32b8c40b6e144c90be5664a97a5355e72023-11-23T20:31:25ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-09-0123191134310.3390/ijms231911343Unraveling Mitochondrial Determinants of Tumor Response to Radiation TherapyMattia Zaffaroni0Maria Giulia Vincini1Giulia Corrao2Giulia Marvaso3Matteo Pepa4Giuseppe Viglietto5Nicola Amodio6Barbara Alicja Jereczek-Fossa7Division of Radiation Oncology, IEO—European Institute of Oncology, IRCCS, 20141 Milan, ItalyDivision of Radiation Oncology, IEO—European Institute of Oncology, IRCCS, 20141 Milan, ItalyDivision of Radiation Oncology, IEO—European Institute of Oncology, IRCCS, 20141 Milan, ItalyDivision of Radiation Oncology, IEO—European Institute of Oncology, IRCCS, 20141 Milan, ItalyDivision of Radiation Oncology, IEO—European Institute of Oncology, IRCCS, 20141 Milan, ItalyDepartment of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100 Catanzaro, ItalyDepartment of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100 Catanzaro, ItalyDivision of Radiation Oncology, IEO—European Institute of Oncology, IRCCS, 20141 Milan, ItalyRadiotherapy represents a highly targeted and efficient treatment choice in many cancer types, both with curative and palliative intents. Nevertheless, radioresistance, consisting in the adaptive response of the tumor to radiation-induced damage, represents a major clinical problem. A growing body of the literature suggests that mechanisms related to mitochondrial changes and metabolic remodeling might play a major role in radioresistance development. In this work, the main contributors to the acquired cellular radioresistance and their relation with mitochondrial changes in terms of reactive oxygen species, hypoxia, and epigenetic alterations have been discussed. We focused on recent findings pointing to a major role of mitochondria in response to radiotherapy, along with their implication in the mechanisms underlying radioresistance and radiosensitivity, and briefly summarized some of the recently proposed mitochondria-targeting strategies to overcome the radioresistant phenotype in cancer.https://www.mdpi.com/1422-0067/23/19/11343mitochondriaradiotherapyradioresistanceROStumor hypoxiamitochondria-targeting compounds
spellingShingle Mattia Zaffaroni
Maria Giulia Vincini
Giulia Corrao
Giulia Marvaso
Matteo Pepa
Giuseppe Viglietto
Nicola Amodio
Barbara Alicja Jereczek-Fossa
Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy
International Journal of Molecular Sciences
mitochondria
radiotherapy
radioresistance
ROS
tumor hypoxia
mitochondria-targeting compounds
title Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy
title_full Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy
title_fullStr Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy
title_full_unstemmed Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy
title_short Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy
title_sort unraveling mitochondrial determinants of tumor response to radiation therapy
topic mitochondria
radiotherapy
radioresistance
ROS
tumor hypoxia
mitochondria-targeting compounds
url https://www.mdpi.com/1422-0067/23/19/11343
work_keys_str_mv AT mattiazaffaroni unravelingmitochondrialdeterminantsoftumorresponsetoradiationtherapy
AT mariagiuliavincini unravelingmitochondrialdeterminantsoftumorresponsetoradiationtherapy
AT giuliacorrao unravelingmitochondrialdeterminantsoftumorresponsetoradiationtherapy
AT giuliamarvaso unravelingmitochondrialdeterminantsoftumorresponsetoradiationtherapy
AT matteopepa unravelingmitochondrialdeterminantsoftumorresponsetoradiationtherapy
AT giuseppeviglietto unravelingmitochondrialdeterminantsoftumorresponsetoradiationtherapy
AT nicolaamodio unravelingmitochondrialdeterminantsoftumorresponsetoradiationtherapy
AT barbaraalicjajereczekfossa unravelingmitochondrialdeterminantsoftumorresponsetoradiationtherapy